SeikagakuSKUNF +0.91%72 Gross Margin % is 48.81% as of Mar. 2026, which is 11% below its 10-year median of 54.55. GuruFocus rates SKUNF with a GF Score™ of 72/100 and a GF Value™ of $17.00 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Seikagaku ranks worse than 64.19% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Seikagaku's Gross Profit for the
three
months ended in Mar. 2026 was $29.9 Mil. Seikagaku's Revenue for the
three
months ended in Mar. 2026 was $61.2 Mil. Therefore, Seikagaku's Gross Margin % for the quarter that ended in Mar. 2026 was 48.81%.
Warning Sign:
Seikagaku Corp gross margin has been in long-term decline. The average rate of decline per year is -5.6%.
The historical rank and industry rank for Seikagaku's Gross Margin % or its related term are showing as below:
SKUNF'
s Gross Margin % Range Over the Past 10 Years
Min: 43.59 Med: 54.55 Max: 58.9
Current: 43.59
During the past 13 years, the highestGross Margin % of Seikagaku was 58.90%. The lowest was 43.59%. And the median was 54.55%.
SKUNF's Gross Margin % is ranked worse than 64.19% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs SKUNF: 43.59
Seikagaku had a gross margin of 48.81% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Seikagaku was -5.60% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Seikagaku had a gross margin of 48.81% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Seikagaku Gross Margin % Related Terms
Seikagaku Gross Margin % Historical Data
* Premium members only.
The historical data trend for Seikagaku's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Seikagaku's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seikagaku Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seikagaku's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Seikagaku's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Seikagaku (SKUNF) has a Gross Margin % of 48.81% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Seikagaku and its competitors. This is 11% below median its historical median of 54.55. Over the past decade, Seikagaku's Gross Margin % has ranged from 43.59 to 58.90. According to the industry distribution chart, Seikagaku ranks #518 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 64.2%.
Is Seikagaku's Gross Margin % too high?
Seikagaku's current Gross Margin % of 48.81% is 11% below median its 10-year median of 54.55. Over the past 10 years, this metric has ranged from a low of 43.59 to a high of 58.90. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Seikagaku's value of 48.81% is 6.2% below this industry median. Based on the distribution chart, Seikagaku ranks #518 out of 807 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Seikagaku has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seikagaku's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Seikagaku ranks #518 out of 807 companies for Gross Margin %. This places Seikagaku in the lower half of its industry. The industry median Gross Margin % is 52.03. Seikagaku's value of 48.81% is 6.2% below this benchmark. Historically, Seikagaku's own Gross Margin % has ranged from 43.59 to 58.90 over the past decade. While the company's 10-year median is 54.55 vs. the industry median of 52.03, Seikagaku has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seikagaku's current Gross Margin % of 48.81% is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Seikagaku and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seikagaku's current Gross Margin % is 48.81%, which is 11% below median its own 10-year median of 54.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seikagaku stock overvalued right now?
Based on GuruFocus' analysis, Seikagaku (SKUNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.00, compared to a current price of $4.44 — trading 73.9% below its estimated fair value. The current Gross Margin % is 48.81%, which is 11% below median its 10-year median of 54.55 and 6.2% below the Medical Devices & Instruments industry median of 52.03. Seikagaku's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Seikagaku (SKUNF), the current Gross Margin % is 48.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seikagaku (SKUNF) Overvalued in 2026?
Based on GuruFocus' analysis, Seikagaku stock appears to be undervalued.
The current stock price of $4.44 is trading 73.9% below its estimated GF Value™ of $17.00.
GuruFocus considers Seikagaku to be Significantly Undervalued.
Key valuation signals for SKUNF:
Gross Margin %: 48.81% (11% below median its 10-year median of 54.55)
GF Value™: $17.00 vs. price of $4.44 (73.9% below fair value)
Industry Position: 6.2% below the Medical Devices & Instruments median (#518 of 807)
No single metric tells the full story. See the SKUNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.
72GF Score
Get the complete analysis for SKUNF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKUNF has been successfully added to your 
